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Diagnostic landscape in the developing world
Accurate diagnostic tests play a key role in patient management and the prevention and control 
of most infectious diseases (Table 1). Early diagnosis and treatment not only reduces the risk of 
developing long-term complications in the patient, but for diseases such as tuberculosis, sexually-
transmitted infections and HIV, prompt treatment also reduces further transmission to other 
members of the community.
In many developing countries, laboratory services are often limited to major urban centres. In 
settings where access to diagnostic laboratory services is limited, the World Health Organization 
(WHO) recommends the use of a syndromic approach to clinical management, where patients 
presenting with a particular syndrome are treated for all the major causes of the syndrome.
Although these algorithms are inexpensive and easy to use, especially in primary healthcare 
settings, a major disadvantage is over-treatment and the potential for development of antibiotic 
resistance. Syndromic management also does not allow contact tracing to prevent onward 
transmission, public health surveillance and interventions.
Even when laboratory services are available, there are often problems with the quality of the 
services due to lack of resources, supply logistics and trained personnel. These problems lead to 
physicians not trusting laboratory results, which in turn leads to further neglect of laboratory 
services.
With the more recent Joint United Nations Programme on HIV/AIDS 90-90-90 targets to identify 
90% of those HIV infected, provide treatment to 90% of those HIV infected, and ensure viral 
suppression for 90% of those on treatment, diagnostics near the point of care will play a pivotal 
role for expanding HIV diagnosis and monitoring.1
Lack of international and national regulatory standards for approval of 
diagnostics
National regulatory processes for drugs provide safeguards for the safety and efficacy of drugs 
used in a country. Most countries have a process for reviewing the evidence from drug trials to 
support the introduction of new drugs, and this has done much to improve the quality of 
therapeutics used in developing countries. Unfortunately, apart from tests used for blood banking, 
regulatory standards are often lacking for diagnostic tests, especially those targeting diseases that 
It is important to consider the role of diagnostics and the critical need for quality diagnostics 
services in resource-limited settings. Accurate diagnostic tests play a key role in patient 
management and the prevention and control of most infectious diseases. As countries plan for 
implementation of HIV early infant diagnosis and viral load point-of-care testing, the London 
School of Hygiene & Tropical Medicine has worked with countries and partners with an interest 
in external quality assurance to support quality point-of-care testing on the continent. Through 
a series of collaborative consultations and workshops, the London School of Hygiene & Tropical 
Medicine has gathered lessons learned, tools, and resources and developed quality assurance 
models that will support point-of-care testing. The London School of Hygiene & Tropical 
Medicine is committed to the continued advancement of laboratory diagnostics in Africa and 
quality laboratory services and point-of-care testing.
External quality assurance for HIV point-of-care testing 
in Africa: A collaborative country-partner approach to 
strengthen diagnostic services
Page 2 of 4 Lessons from the Field
http://www.ajlmonline.org Open Access
are uncommon in industrialised countries. As a result, 
diagnostic tests are often sold in most of the developing 
world, without any formal evaluation of their performance 
and effectiveness.
Ten years of building capacity to 
assure quality
In a review article by Petti et al. in 2006, the authors described 
laboratory medicine as a barrier to effective healthcare, with 
misdiagnosis occurring often.2 Clinicians must rely on 
alternative diagnostics in their clinical practice due to the 
lack of available and affordable diagnostics. This article 
elicited numerous responses, acknowledging diagnostic 
insufficiencies in Africa, and even referring to laboratory 
systems and diagnostics as the Achilles Heel of global 
health.3,4 As of 10 years ago, we understood the need for 
sustainable laboratory infrastructures to support the 
diagnosis of infectious disease.
Since 2008, there have been several landmark events to 
advance laboratory diagnostics in Africa:
•	 2008: January – the Maputo Declaration for strengthening 
laboratory health systems;5 April – the Lyon Statement on 
the need for developing countries to establish practical 
quality management systems;6 and September – the 
Yaoundé resolution issued by the WHO Regional Office 
for Africa (WHO AFRO) to strengthen public health 
laboratories in the WHO African region;7
•	 July 2009: Several African countries, donors, WHO and 
implementing partners met in Kigali, Rwanda, to launch 
the Stepwise Laboratory Quality Improvement Process 
Towards Accreditation (SLIPTA), the WHO AFRO 
accreditation scheme to assist laboratories in obtaining 
internationally-recognised accreditation standards8 
(ISO – International Organization for Standardization; 
CAP – College of American Pathologists; SANAS – South 
African National Accreditation System; SADCAS – 
Southern African Development Community Accreditation 
Service);
•	 2010: The Kampala Statement called for the creation of 
the African Society for Laboratory Medicine;9
•	 2011: Launch of the African Society for Laboratory 
Medicine as a pan-African professional body working to 
advocate for the critical role and needs of laboratory 
medicine and networks throughout Africa. The African 
Society for Laboratory Medicine addresses these 
challenges by working collaboratively with governments, 
local and international organisations, implementing 
partners, and the private sector to achieve the following 
goals by 2020:
■ Strengthening laboratory workforce by training and 
certifying laboratory professionals and clinicians 
through standardised frameworks;
■ Transforming laboratory testing quality by enrolling 
laboratories in quality improvement programmes to 
achieve accreditation by international standards;
■ Developing strong, harmonised regulatory systems 
for diagnostic products as defined by the Global 
Harmonization Taskforce; and
■ Building a network of national public health 
reference laboratories to improve early disease 
detection and collaborative research.
•	 2015: WHO/US Centers for Disease Control and 
Prevention point-of-care (POC) handbook;10
•	 2016: 27 of the 47 (57%) WHO AFRO member states had 
appointed a SLIPTA focal point and 14 Ministers of 
Health had endorsed SLIPTA as the desired programme 
for continuous quality improvement. 159 laboratories 
were audited between May 2013 and March 2015, with a 
69% mean score. Of those audited, 70% achieved 55% 
compliance or higher (2 or more stars) and 1% scored at 
least 95% (5 stars). The lowest scoring sections of the 
WHO AFRO SLIPTA checklist were sections 6 (Internal 
Audit) and 10 (Corrective Action), which both had mean 
scores below 50%.8 Figure 1 shows the scoring system 
(stars) as outlined by the SLIPTA inspection checklist.
This progress is very encouraging, but there are new 
challenges with the introduction of POC testing:
•	 POC testing is performed and results interpreted by non-
lab personnel with no expertise or experience in doing 
any form of testing;
•	 POC devices and cartridges are transported all over the 
country without temperature control;
No Stars
(0–142 pts)
< 55%
1 Star
(143–165 pts)
55–64%
2 Stars
(166–191 pts)
65–74%
3 Stars
(192–217 pts)
75–84%
4 Stars
(218–243 pts)
85–94%
5 Stars
(244–258 pts)
≥ 95%
FIGURE 1: Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) inspection checklist score corresponds to the number of stars awarded to a 
laboratory. 
TABLE 1: Role of diagnostic tests in patient management and disease control.
Aspects of patient management and 
disease control
Role of diagnostic tests
Case management Screening for asymptomatic infections
Diagnosis and/or staging of infections 
when clinical presentation is non-specific
Disease control Surveillance
Outbreak investigations
Monitoring the effectiveness of 
interventions
Elimination Certifying elimination
Treatment efficacy Detecting and monitoring drug resistance
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•	 POC devices and cartridges stored at remote sites often have 
no temperature control. The devices may be dusty or exposed 
to extreme humidity. All of these affect the test validity;
•	 Many POC tests lack ‘on-board’ controls, meaning that 
there is no quality control for the testing process;
•	 Central or national laboratories often do not have sufficient 
capacity to supervise all POC testing or institute external 
quality assessment (EQA) programmes for every POC site.
A collaborative approach to assure quality
In consultation with the Ministry of Health and representatives 
from 10 countries with an interest in external quality 
assurance, the London School of Hygiene and Tropical 
Medicine, through funding from UNITAID, worked with 
partners and quality assurance experts to develop strategies 
and initiatives to support countries in scaling up quality POC 
testing. Countries shared lessons learned and possible 
planning for quality POC testing.
Quality assurance models for point-of-care 
testing
While POC has the potential to provide faster results 
for quicker clinical decisions, a major concern with 
decentralising diagnostics and laboratory services is the lack 
of oversight and ensuring quality standards. From the 
consultations, several models were captured for organising 
POC testing in Africa (Figure 2).
Quality assurance/external quality assurance 
consultations for point-of-care testing
Initial country consultations with UNICEF
These consultations found a large need for quality assurance 
planning and policies, especially around POC testing.
Regional country consultations (East and West Africa)
This set the stage for our EQA work, as we found that most 
countries were enrolled in some sort of EQA programme and 
were also supporting quality assurance activities. Countries 
shared lessons and tools and identified major gaps in their 
quality assurance programmes.
US Centers for Disease Control and Prevention, Atlanta, 
external quality assessment workshops
These brought together EQA providers as a think tank for 
global proficiency testing schemes, EQA programmes, and 
capacity building.
External quality assessment country pilot
This piloted full coverage of EQA for CD4 POC in one 
country, which helped the country map the POC landscape 
Centralized
Naonal
Reference
Laboratory
QA
QA
QA
QA
QA
Decentralized
Centralized
Tesng
Centralized
Tesng
Centralized
Tesng
Regional
NRL or CTL
HUBS
HUBS
= POCT
HUBS
1. Mapping disease prevalence
2. EQA (acve, intermediate, passive)
• Producon
• Packaging/Shipping
• Program Management
4. Cost
3. Data/Connecvity
Proposed QA Framework
QA, quality assurance; EQA, external quality assessment; NRL, national reference laboratory; CTL, centralised testing laboratory.
FIGURE 2: Quality assurance models for point-of-care testing integrated within existing laboratory networks. 
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and identify gaps and challenges (e.g. broken instruments, 
supply chain management issues).
External quality assessment/Connectivity pilot
This programme explored how to monitor quality assurance 
of POC testing. It identified numerous gaps as well as 
promising opportunities with connectivity and automated 
EQA reporting.
Costing workshops
Countries shared costing information and were trained by 
modellers and economists to perform costing exercises. This 
information has formed the basis for costing quality 
assurance as a percentage of the total cost of a POC test. 
This information can be used for advocacy and budget 
planning, as well as business plan development.
Technical external quality assessment workshops
A series of technical workshops to provide global coverage 
for HIV CD4, EID, and viral load external quality assurance, 
including proficiency testing schemes, and to transition 
EQA programmes to the continent through technology 
transfer trainings and capacity-building discussions. These 
workshops will also support regional EQA centres and 
south-to-south collaborations.
Conclusions and way forward
Diagnostics have become central to patient management and 
disease surveillance/control in the developing world. As 
laboratory testing is pushed to more remote areas, ensuring 
accurate diagnostic results as well as sustainable laboratory 
services becomes a greater challenge to systems that are 
already struggling.
The London School of Hygiene & Tropical Medicine is 
working to continue the advancement of laboratory 
diagnostics in Africa, working with African countries and 
partners with an interest in EQA to support quality POC 
testing on the continent. Through a series of collaborative 
consultations and workshops, the London School of Hygiene 
and Tropical Medicine has gathered lessons learned, tools 
and resources, and developed quality assurance models that 
will support POC testing.
It is important to consider the role of diagnostics and the 
critical need for quality diagnostics services in the more 
remote resource-limited settings. Clinicians and patients will 
increasingly depend on POC testing for improved health 
outcomes. At the same time, these new diagnostics should be 
seen as opportunities to improve the health of the community 
with surveillance and disease control programmes.
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